Literature DB >> 28060720

iNKT and memory B-cell alterations in HHV-8 multicentric Castleman disease.

Zineb Sbihi1, Antoine Dossier1,2, David Boutboul3, Lionel Galicier3, Christophe Parizot1,4, Amandine Emarre1, Bénédicte Hoareau5, Nicolas Dupin6, Anne-Geneviève Marcelin7,8, Anne Oudin1, Claire Fieschi3, Félix Agbalika9, Brigitte Autran1,4, Eric Oksenhendler3, Guislaine Carcelain1,4.   

Abstract

Human herpesvirus 8 (HHV-8) is the causative agent of Kaposi sarcoma (KS) and multicentric Castleman disease (MCD), a life-threatening, virally induced B-cell lymphoproliferative disorder. HHV-8 is a B-lymphotropic γ-herpesvirus closely related to the Epstein-Barr virus (EBV). Invariant natural killer T (iNKT) cells are innate-like T cells that play a role in antiviral immunity, specifically in controlling viral replication in EBV-infected B cells. Decline of iNKT cells is associated with age or HIV infection, both situations associated with HHV-8-related diseases. We analyzed iNKT cells in both blood (n = 26) and spleen (n = 9) samples from 32 patients with HHV-8 MCD and compared them with patients with KS (n = 24) and healthy donors (n = 29). We determined that both circulating and splenic iNKT cell frequencies were markedly decreased in patients with HHV-8 MCD and were undetectable in 6 of them. Moreover, iNKT cells from patients with HHV-8 MCD displayed a proliferative defect after stimulation with α-galactosylceramide. These iNKT cell alterations were associated with an imbalance in B-cell subsets, including a significant decrease in memory B cells, particularly of marginal zone (MZ) B cells. Coculture experiments revealed that the decrease in iNKT cells contributed to the alterations in the B-cell subset distribution. These observations contribute to a better understanding of the complex interactions between HHV-8 and immune cells that cause HHV-8-related MCD.
© 2017 by The American Society of Hematology.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 28060720     DOI: 10.1182/blood-2016-06-719716

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  10 in total

Review 1.  Extrafollicular activities: perspectives on HIV infection, germinal center-independent maturation pathways, and KSHV-mediated lymphoproliferation.

Authors:  Jennifer Totonchy
Journal:  Curr Opin Virol       Date:  2017-08-03       Impact factor: 7.090

Review 2.  Immune evasion of the CD1d/NKT cell axis.

Authors:  Randy R Brutkiewicz; Laura Yunes-Medina; Jianyun Liu
Journal:  Curr Opin Immunol       Date:  2018-05-04       Impact factor: 7.486

3.  iNKT cell defects in HHV-8-associated MCD.

Authors:  Thomas S Uldrick
Journal:  Blood       Date:  2017-02-16       Impact factor: 22.113

Review 4.  HIV-associated Kaposi sarcoma and related diseases.

Authors:  Priscila H Gonçalves; Thomas S Uldrick; Robert Yarchoan
Journal:  AIDS       Date:  2017-09-10       Impact factor: 4.177

Review 5.  Treatment of Kaposi Sarcoma Herpesvirus-Associated Multicentric Castleman Disease.

Authors:  Kathryn Lurain; Robert Yarchoan; Thomas S Uldrick
Journal:  Hematol Oncol Clin North Am       Date:  2018-02       Impact factor: 3.722

Review 6.  Invariant natural killer T cells balance B cell immunity.

Authors:  Elizabeth A Leadbetter; Mikael C I Karlsson
Journal:  Immunol Rev       Date:  2021-01-12       Impact factor: 12.988

Review 7.  The Influence of Invariant Natural Killer T Cells on Humoral Immunity to T-Dependent and -Independent Antigens.

Authors:  Mark L Lang
Journal:  Front Immunol       Date:  2018-02-22       Impact factor: 7.561

Review 8.  Clonality, Mutation and Kaposi Sarcoma: A Systematic Review.

Authors:  Blanca Iciar Indave Ruiz; Subasri Armon; Reiko Watanabe; Lesley Uttley; Valerie A White; Alexander J Lazar; Ian A Cree
Journal:  Cancers (Basel)       Date:  2022-02-25       Impact factor: 6.639

Review 9.  CD1-Restricted T Cells During Persistent Virus Infections: "Sympathy for the Devil".

Authors:  Günther Schönrich; Martin J Raftery
Journal:  Front Immunol       Date:  2018-03-19       Impact factor: 7.561

Review 10.  Activation and Regulation of B Cell Responses by Invariant Natural Killer T Cells.

Authors:  Derek G Doherty; Ashanty M Melo; Ana Moreno-Olivera; Andreas C Solomos
Journal:  Front Immunol       Date:  2018-06-18       Impact factor: 7.561

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.